Allergan Calls Truce Over Special Shareholders MeetingMani
Allergan, Inc. (NYSE:AGN) has reached an agreement with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Pershing Square Capital Management to hold a special shareholder meeting on the originally scheduled date, Dec. 18, thus ending one contentious scene in their tussle.
Allergan’s shareholders of record on Oct. 30 will be entitled to receive notice and vote at the Dec. 18 meeting.
Ackman’s push for the Allergan shareholder meeting
exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible